Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001962515 | SCV002211552 | pathogenic | not provided | 2023-07-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1434715). This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser612*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). |
Institute of Medical Genetics and Applied Genomics, |
RCV004546689 | SCV005043149 | pathogenic | Usher syndrome type 1 | 2024-05-10 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV004571655 | SCV005051870 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 2 | 2024-02-01 | criteria provided, single submitter | curation |